<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04089306</url>
  </required_header>
  <id_info>
    <org_study_id>7424</org_study_id>
    <nct_id>NCT04089306</nct_id>
  </id_info>
  <brief_title>Integration of Palliative Care in an Oncology and Hematology Unit</brief_title>
  <official_title>Integration of Palliative Care in an Oncology and Hematology Unit : a Retrospective Monocentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this study is to assess retrospectively the integration of Palliative Care
      in an oncology and hematology unit. The investigators will study the last six month of life
      on advanced cancer patients and retrieve data from their medical file to obtain criterias of
      quality of care and integration of palliative care in this population.

      Those criterias have been used before in other setting (Earle Criterias, ESMO
      Recommendations) and The investigators will compare our data to existing publications.

      They also hope to see if it is retrospectively possible to assess the probability of death
      using the Pronopall score. This will help them asses if aggressive end of life care could
      have been avoided using the Pronopall Score
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective study of palliative care in oncohematology department</measure>
    <time_frame>The period from January 1st, 2017 to December 31, 2018 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Advanced Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who has been followed in the oncohematology Unit of the University Hospital of
        Strasbourg for a solid tumor or haematological cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged over 18 years old

          -  Patient who has been followed in the oncohematology Unit of the University Hospital of
             Strasbourg for a solid tumor or haematological cancer

          -  Died within the 1rst of January 2017 and the 31st of December 2018

          -  The patient has not expressed an opposition to the use of his medical data during his
             lifetime.

        Exclusion Criteria:

          -  Patient receiving allogeneic stem cell transplant

          -  Patient expressed during his lifetime an opposition regarding the use of his medical
             data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Gabriel MALOUF, MD, PhD</last_name>
    <phone>03 88 11 62 22</phone>
    <email>gabriel.malouf@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service D'Hematologie Et D'Oncologie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Gabriel MALOUF, MD, PhD</last_name>
      <phone>03 88 11 62 22</phone>
      <email>gabriel.malouf@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Gabriel MALOUF, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe TRENSZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Emanuel KURTZ, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raoul HERBRECHT, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fran√ßois LEFEBVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Advanced Cancer</keyword>
  <keyword>End of Life</keyword>
  <keyword>Agressiveness of Care</keyword>
  <keyword>Palliative Care integration</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

